Company intelligence / Profile preview

Solace Therapeutics

Framingham, Massachusetts, United States6sense.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Solace Therapeutics developed the Vesair® Bladder Control System, a non-surgical, office-based device intended to treat female stress urinary incontinence. The company has conducted multiple clinical trials including pivotal studies; however, at least two major clinical trials were terminated before completion. The technology is designed to offer a reversible alternative to surgery or drug therapy with minimal side effects[3][6][7].

Therapeutic areas: Men's HealthUrologyWomen's Health
Modalities: DeviceNon-pharmacological therapy (office-based medical device)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Vesair Bladder Control System

Phase 3

Indications: Stress Urinary Incontinence

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Solace Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solace Therapeutics.

Explore the full profile